Arming oncolytic viruses to leverage antitumor immunity

摘要

Introduction: Over the past decade, the cytolytic capabilities of oncolytic viruses (OVs), exploited to selectively eliminate neoplastic cells, have become secondary to their use to elicit a tumor-directed immune response.